People: Bio-Rad Laboratories Inc (BIO.N)
115.94USD
3:34pm EDT
$-0.47 (-0.40%)
$116.41
$116.13
$116.31
$115.77
15,836
25,055
$126.40
$91.52
Neff, Deborah
Brief Biography
Ms. Deborah J. Neff serves as Independent Director of Bio Rad Laboratories Inc., since October 26, 2011. Ms. Neff is currently an executive advisor in the health care industry. From 2006 to 2012, she was President and Chief Executive Officer of Pathwork Diagnostics, Inc. From 2003 to 2006, she was the Chief Executive Officer of Predicant Biosciences. From 1988 to 2003, she served in various positions at BD Biosciences, including as worldwide President from 1995 to 2003.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Norman Schwartz |
4,520,750 |
Christine Tsingos |
825,846 |
Sanford Wadler |
663,774 |
Bradford Crutchfield |
786,453 |
John Goetz |
1,159,850 |
Giovanni Magni |
815,559 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
